resveratrol has been researched along with zileuton in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, M; Bauer, R; Greger, H; Pacher, T | 1 |
Dansette, PM; Fontana, E; Poli, SM | 1 |
Alessio, N; Ambruosi, M; Banoglu, E; Boccellino, M; Bruno, F; De Rosa, M; Donniacuo, M; Filosa, R; Fiorentino, A; Kahn, H; Massa, A; OlgaƧ, A; Pace, S; Quagliuolo, L; Rinaldi, B; Werz, O | 1 |
1 review(s) available for resveratrol and zileuton
Article | Year |
---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
2 other study(ies) available for resveratrol and zileuton
Article | Year |
---|---|
Inhibition of leukotriene biosynthesis by stilbenoids from Stemona species.
Topics: Alkaloids; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Leukotrienes; Molecular Structure; Plants, Medicinal; Resveratrol; Stemonaceae; Stilbenes; Thailand | 2005 |
Protective effect of piceatannol and bioactive stilbene derivatives against hypoxia-induced toxicity in H9c2 cardiomyocytes and structural elucidation as 5-LOX inhibitors.
Topics: Animals; Arachidonate 5-Lipoxygenase; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Hypoxia; Lipoxygenase Inhibitors; Molecular Structure; Myocytes, Cardiac; Protective Agents; Rats; Stilbenes; Structure-Activity Relationship | 2019 |